Newsroom

September 21, 2022

Tasly Pharmaceuticals to Exhibit at BioJapan 2022

 1,219 total views,  3 views today Bio-pharmaceutical company to join with Maryland-based organizations at Asia’s premier biotechnology partnering event Rockville, MD – October 5, 2022 – Tasly Pharmaceuticals, Inc. (Tasly U.S.), “dedicated to a healthier world,” will join a delegation of  other Maryland-based bio-pharmaceutical companies at BioJapan 2022, Asia’s premier partnering event for the global biotechnology sector, […]

News
July 15, 2022

What makes Tasly a great company to invest in?

 30,031 total views,  11 views today If you’re interested in shaping the future of Western medicine by improving the quality of life for people in the U.S. and around the world, then you should consider investing in Tasly US. We’re focused on the research and development of Traditional Chinese Medicine (TCM) and want to apply the practices that […]

News
June 10, 2022

Cardiovascular (T89) Drug Updates

 56,558 total views,  3 views today Tests show it can reduce chronic stable angina. Tasly Pharmaceuticals Inc(Tasly US), is nearing the end of what has been a long road of testing to get approval from the US Food and Drug Administration (FDA) for its T89 drug (Dantonic), multiple components innovative Chinese Medicine (ICM). Dantonic, the drug has been […]

News
May 18, 2022

Tasly in Cooperation with Azurity on T89 R&D and Marketing

 17,697 total views,  2 views today Tasly Pharmaceutical Group Co., Ltd. (referred to as “Tasly”) and the US-based drug maker Azurity Pharmaceuticals, Inc. (referred to as “Azurity”) announced on Sep. 6 comprehensive cooperation in the R&D and marketing of T89 in the States. According to their agreement, Azurity will contribute an amount up to US$23 million for […]

News
May 17, 2018

Tasly Presents Breakthrough Angina Herbal Compound to American College of Cardiologists

 16,535 total views,  1 views today ROCKVILLE, MD – Tasly Pharmaceuticals Co. Ltd. of China and Tasly Pharmaceuticals, Inc. of USA, a global leader in pharmaceuticals, biologics and nutraceuticals, announced that its three-herb composition drug T89 (Dantonic), has been shown in a Phase 3 global clinical trial to improve Treadmill exercise duration (TED) and more effectively reduce […]

News
May 17, 2018

Dr. Henry Sun Gives Keynote at ACC18 on Herbal Therapy for Heart Disease

 14,550 total views,  2 views today On March 12, 2018, Dr. Henry Sun, Ph.D., and CEO/President of Tasly Pharmaceuticals, Inc. took the stage at this year’s American College of Cardiology (ACC) conference as a keynote speaker to present on a new topic. He spoke about the future of herbal therapies to support heart disease treatments, citing a […]

News
February 3, 2015

An Important Announcement from Our CEO

 13,678 total views,  1 views today To Our Valued Customers, Patients, Healthcare Providers, and Business Partners, On February 3, 2015, the New York State Attorney General’s Office accused four national retailers of selling dietary supplements that were fraudulent and in many cases contaminated with unlisted ingredients.  Although we cannot comment on this and will not make any […]

News
August 27, 2014

Tasly Comes to America

 14,052 total views,  2 views today Rockville, MD – PR Newswire – 27 August 2014 – On September 3, 2014, Tasly Pharmaceuticals, Inc., a global leader in Pharmaceuticals, Biologics, and Nutraceuticals, hosted a ribbon-cutting event at its corporate headquarters in Rockville, Maryland. The ceremony included over 150 distinguished guests and dignitaries, including Tasly’s corporate leaders, Maryland state […]

News